

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.87581851 |
| 2 | skeletal muscle contraction (GO:0003009) | 6.35788775 |
| 3 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 6.24673894 |
| 4 | substrate-independent telencephalic tangential migration (GO:0021826) | 6.24673894 |
| 5 | dopamine transport (GO:0015872) | 6.10177686 |
| 6 | peristalsis (GO:0030432) | 5.60909993 |
| 7 | drug transmembrane transport (GO:0006855) | 5.48227174 |
| 8 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 5.35870738 |
| 9 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 5.35870738 |
| 10 | lysine catabolic process (GO:0006554) | 5.18189871 |
| 11 | lysine metabolic process (GO:0006553) | 5.18189871 |
| 12 | urate metabolic process (GO:0046415) | 5.09079949 |
| 13 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.92582704 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.87900661 |
| 15 | response to muscle activity (GO:0014850) | 4.87250432 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 4.81049221 |
| 17 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.79015853 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.67790330 |
| 19 | striated muscle contraction (GO:0006941) | 4.64678793 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.64178620 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 4.64178620 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.64178620 |
| 23 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.63934623 |
| 24 | regulation of neurotransmitter uptake (GO:0051580) | 4.63146039 |
| 25 | striatum development (GO:0021756) | 4.62052916 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.56878339 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.55462555 |
| 28 | quaternary ammonium group transport (GO:0015697) | 4.45999352 |
| 29 | desmosome organization (GO:0002934) | 4.39275065 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 4.38173143 |
| 31 | maternal behavior (GO:0042711) | 4.29629135 |
| 32 | actin filament-based movement (GO:0030048) | 4.29581763 |
| 33 | tryptophan metabolic process (GO:0006568) | 4.29443286 |
| 34 | drug transport (GO:0015893) | 4.29061587 |
| 35 | myofibril assembly (GO:0030239) | 4.28462717 |
| 36 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.25578356 |
| 37 | carnitine transport (GO:0015879) | 4.23575828 |
| 38 | amino-acid betaine transport (GO:0015838) | 4.23575828 |
| 39 | skeletal muscle fiber development (GO:0048741) | 4.22934441 |
| 40 | kynurenine metabolic process (GO:0070189) | 4.21103096 |
| 41 | behavioral response to cocaine (GO:0048148) | 4.20606008 |
| 42 | organic cation transport (GO:0015695) | 4.20503018 |
| 43 | negative regulation of cAMP-mediated signaling (GO:0043951) | 4.15668803 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.14936262 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.13104829 |
| 46 | L-phenylalanine catabolic process (GO:0006559) | 4.13104829 |
| 47 | cerebellar granule cell differentiation (GO:0021707) | 4.10202385 |
| 48 | cell proliferation in forebrain (GO:0021846) | 4.05358996 |
| 49 | muscle contraction (GO:0006936) | 4.04655398 |
| 50 | short-chain fatty acid metabolic process (GO:0046459) | 4.04076201 |
| 51 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.02534676 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 4.02485150 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.02485150 |
| 54 | carnitine metabolic process (GO:0009437) | 4.01553006 |
| 55 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.01165601 |
| 56 | parental behavior (GO:0060746) | 3.98902128 |
| 57 | prepulse inhibition (GO:0060134) | 3.97749177 |
| 58 | catecholamine transport (GO:0051937) | 3.95576330 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93718090 |
| 60 | myotube cell development (GO:0014904) | 3.93392269 |
| 61 | drug catabolic process (GO:0042737) | 3.91991929 |
| 62 | fatty acid beta-oxidation (GO:0006635) | 3.89162495 |
| 63 | valine metabolic process (GO:0006573) | 3.88545719 |
| 64 | glycogen catabolic process (GO:0005980) | 3.88376524 |
| 65 | cardiac muscle hypertrophy (GO:0003300) | 3.86467462 |
| 66 | phasic smooth muscle contraction (GO:0014821) | 3.79659766 |
| 67 | neuronal action potential (GO:0019228) | 3.79223081 |
| 68 | exogenous drug catabolic process (GO:0042738) | 3.75655522 |
| 69 | auditory receptor cell stereocilium organization (GO:0060088) | 3.75640028 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.74791368 |
| 71 | homocysteine metabolic process (GO:0050667) | 3.74235151 |
| 72 | cysteine metabolic process (GO:0006534) | 3.73893627 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 3.73757577 |
| 74 | transmission of nerve impulse (GO:0019226) | 3.73157441 |
| 75 | branched-chain amino acid metabolic process (GO:0009081) | 3.72872795 |
| 76 | regulation of cardioblast proliferation (GO:0003264) | 3.72535385 |
| 77 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.72535385 |
| 78 | muscle system process (GO:0003012) | 3.71459145 |
| 79 | response to inactivity (GO:0014854) | 3.71303806 |
| 80 | striated muscle hypertrophy (GO:0014897) | 3.67337165 |
| 81 | phosphate ion transport (GO:0006817) | 3.67137185 |
| 82 | carnitine shuttle (GO:0006853) | 3.63091881 |
| 83 | mating behavior (GO:0007617) | 3.60422244 |
| 84 | lens fiber cell development (GO:0070307) | 3.57258831 |
| 85 | ubiquinone biosynthetic process (GO:0006744) | 3.56783808 |
| 86 | glucan catabolic process (GO:0009251) | 3.56664213 |
| 87 | synaptic transmission, dopaminergic (GO:0001963) | 3.55722325 |
| 88 | carnitine transmembrane transport (GO:1902603) | 3.55458182 |
| 89 | cardiac muscle adaptation (GO:0014887) | 3.55383310 |
| 90 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.55383310 |
| 91 | muscle hypertrophy in response to stress (GO:0003299) | 3.55383310 |
| 92 | fatty acid oxidation (GO:0019395) | 3.52510789 |
| 93 | serine family amino acid catabolic process (GO:0009071) | 3.51944432 |
| 94 | response to mercury ion (GO:0046689) | 3.51821864 |
| 95 | positive regulation of potassium ion transport (GO:0043268) | 3.51462000 |
| 96 | cytidine metabolic process (GO:0046087) | 3.51414786 |
| 97 | cytidine catabolic process (GO:0006216) | 3.51414786 |
| 98 | cytidine deamination (GO:0009972) | 3.51414786 |
| 99 | striated muscle adaptation (GO:0014888) | 3.48578149 |
| 100 | maturation of 5.8S rRNA (GO:0000460) | 3.47487438 |
| 101 | lipid oxidation (GO:0034440) | 3.44154420 |
| 102 | regulation of cell communication by electrical coupling (GO:0010649) | 3.43719225 |
| 103 | muscle fiber development (GO:0048747) | 3.42332422 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 3.39817313 |
| 105 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.38845061 |
| 106 | skeletal muscle adaptation (GO:0043501) | 3.38611547 |
| 107 | dentate gyrus development (GO:0021542) | 3.37739952 |
| 108 | ubiquinone metabolic process (GO:0006743) | 3.36813436 |
| 109 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.36774531 |
| 110 | fatty acid transmembrane transport (GO:1902001) | 3.36548122 |
| 111 | tricarboxylic acid metabolic process (GO:0072350) | 3.34623125 |
| 112 | regulation of skeletal muscle contraction (GO:0014819) | 3.30592574 |
| 113 | adult walking behavior (GO:0007628) | 3.30329030 |
| 114 | cellular polysaccharide catabolic process (GO:0044247) | 3.27262917 |
| 115 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.26953445 |
| 116 | regulation of hexokinase activity (GO:1903299) | 3.26684212 |
| 117 | regulation of glucokinase activity (GO:0033131) | 3.26684212 |
| 118 | fatty acid catabolic process (GO:0009062) | 3.24290760 |
| 119 | branched-chain amino acid catabolic process (GO:0009083) | 3.23869312 |
| 120 | cardiac muscle contraction (GO:0060048) | 3.23612728 |
| 121 | neuron fate determination (GO:0048664) | 3.22971748 |
| 122 | glycogen biosynthetic process (GO:0005978) | 3.22244460 |
| 123 | glucan biosynthetic process (GO:0009250) | 3.22244460 |
| 124 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.22000004 |
| 125 | phosphate ion transmembrane transport (GO:0035435) | 3.21317285 |
| 126 | cellular modified amino acid catabolic process (GO:0042219) | 3.20101445 |
| 127 | muscle hypertrophy (GO:0014896) | 3.19794150 |
| 128 | biotin metabolic process (GO:0006768) | 3.17432980 |
| 129 | neuronal action potential propagation (GO:0019227) | 3.16327460 |
| 130 | indolalkylamine metabolic process (GO:0006586) | 3.15306180 |
| 131 | muscle filament sliding (GO:0030049) | 3.15299580 |
| 132 | actin-myosin filament sliding (GO:0033275) | 3.15299580 |
| 133 | cellular biogenic amine catabolic process (GO:0042402) | 3.14014197 |
| 134 | amine catabolic process (GO:0009310) | 3.14014197 |
| 135 | aromatic amino acid family metabolic process (GO:0009072) | 3.12670578 |
| 136 | monocarboxylic acid catabolic process (GO:0072329) | 3.12433112 |
| 137 | regulation of actin filament-based movement (GO:1903115) | 3.10945551 |
| 138 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10000147 |
| 139 | benzene-containing compound metabolic process (GO:0042537) | 3.09269104 |
| 140 | sex differentiation (GO:0007548) | 3.06413079 |
| 141 | ethanol oxidation (GO:0006069) | 3.06273468 |
| 142 | trivalent inorganic anion homeostasis (GO:0072506) | 3.05442752 |
| 143 | phosphate ion homeostasis (GO:0055062) | 3.05442752 |
| 144 | neuromuscular synaptic transmission (GO:0007274) | 3.03487856 |
| 145 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.02726473 |
| 146 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.02726473 |
| 147 | alpha-amino acid catabolic process (GO:1901606) | 3.02655843 |
| 148 | skeletal muscle tissue development (GO:0007519) | 3.01424397 |
| 149 | response to phenylpropanoid (GO:0080184) | 3.00630069 |
| 150 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.98970751 |
| 151 | muscle cell cellular homeostasis (GO:0046716) | 2.98083841 |
| 152 | long term synaptic depression (GO:0060292) | 2.96866107 |
| 153 | polysaccharide catabolic process (GO:0000272) | 2.96398252 |
| 154 | actomyosin structure organization (GO:0031032) | 2.92069225 |
| 155 | vitamin D metabolic process (GO:0042359) | 2.90102345 |
| 156 | asymmetric protein localization (GO:0008105) | 2.89067617 |
| 157 | hemidesmosome assembly (GO:0031581) | 2.87882573 |
| 158 | B cell receptor signaling pathway (GO:0050853) | 2.87763896 |
| 159 | positive regulation of synapse assembly (GO:0051965) | 2.87059781 |
| 160 | regulation of catecholamine metabolic process (GO:0042069) | 2.87009077 |
| 161 | regulation of dopamine metabolic process (GO:0042053) | 2.87009077 |
| 162 | cellular amino acid catabolic process (GO:0009063) | 2.84922633 |
| 163 | cellular ketone body metabolic process (GO:0046950) | 2.83903377 |
| 164 | bile acid biosynthetic process (GO:0006699) | 2.83377988 |
| 165 | sarcomere organization (GO:0045214) | 2.83051060 |
| 166 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.82448580 |
| 167 | muscle adaptation (GO:0043500) | 2.82439503 |
| 168 | organic acid catabolic process (GO:0016054) | 2.81579658 |
| 169 | carboxylic acid catabolic process (GO:0046395) | 2.81579658 |
| 170 | fructose metabolic process (GO:0006000) | 2.81282550 |
| 171 | heart contraction (GO:0060047) | 2.80371294 |
| 172 | heart process (GO:0003015) | 2.80371294 |
| 173 | quinone biosynthetic process (GO:1901663) | 2.79093179 |
| 174 | cardiac myofibril assembly (GO:0055003) | 2.78402951 |
| 175 | creatine metabolic process (GO:0006600) | 2.78307371 |
| 176 | grooming behavior (GO:0007625) | 2.78128840 |
| 177 | cellular glucuronidation (GO:0052695) | 2.77719678 |
| 178 | regulation of membrane repolarization (GO:0060306) | 2.76984523 |
| 179 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.76213793 |
| 180 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.75179611 |
| 181 | actin-mediated cell contraction (GO:0070252) | 2.70823016 |
| 182 | regulation of cholesterol homeostasis (GO:2000188) | 2.67780703 |
| 183 | sulfur amino acid catabolic process (GO:0000098) | 2.65195656 |
| 184 | complement activation, classical pathway (GO:0006958) | 2.63938045 |
| 185 | phospholipid homeostasis (GO:0055091) | 2.61997576 |
| 186 | ethanol metabolic process (GO:0006067) | 2.61338041 |
| 187 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.59648834 |
| 188 | glucuronate metabolic process (GO:0019585) | 2.56919637 |
| 189 | uronic acid metabolic process (GO:0006063) | 2.56919637 |
| 190 | plasma membrane repair (GO:0001778) | 2.55575661 |
| 191 | positive thymic T cell selection (GO:0045059) | 2.53916564 |
| 192 | regulation of bile acid biosynthetic process (GO:0070857) | 2.51554699 |
| 193 | excretion (GO:0007588) | 2.51053165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.74205613 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.80065720 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.75910305 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.39376939 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.31465190 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.91978622 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.73007463 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.39001453 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.28714231 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18708989 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.96557473 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.77739070 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.77490637 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.41685915 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.37744812 |
| 16 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.29974984 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.27388243 |
| 18 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10189869 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08696443 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.08429848 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97957524 |
| 22 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.94523080 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.93148752 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.91654390 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.91527894 |
| 26 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.89965721 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89171198 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84252915 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76295840 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75111836 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74621842 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.74003232 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69647140 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.68204822 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.68204822 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66639844 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65891350 |
| 38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.59963935 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57881550 |
| 40 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.56023337 |
| 41 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.55160252 |
| 42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.51909454 |
| 43 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.51024052 |
| 44 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.49090570 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48158993 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46433508 |
| 47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.44111444 |
| 48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.43055869 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42795378 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41183946 |
| 51 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40379555 |
| 52 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.36606228 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36027154 |
| 54 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34709594 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34545378 |
| 56 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32156727 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32002429 |
| 58 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29603584 |
| 59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28324688 |
| 60 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.27225551 |
| 61 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.27066002 |
| 62 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.26358245 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25937994 |
| 64 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24952681 |
| 65 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.24650310 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24096458 |
| 67 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22661907 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21070189 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21070189 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20799532 |
| 71 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20700475 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20054464 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19131493 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18930086 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18043013 |
| 76 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17789477 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15623235 |
| 78 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14904074 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14364199 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13421126 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12857345 |
| 82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12857345 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12428247 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12355600 |
| 85 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12004854 |
| 86 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11804947 |
| 87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11712117 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11523211 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10846064 |
| 90 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10661703 |
| 91 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.10308867 |
| 92 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09338765 |
| 93 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08828859 |
| 94 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08530861 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08476599 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08387799 |
| 97 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07517835 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07105252 |
| 99 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06166072 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05888718 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04939523 |
| 102 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.04722289 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03986251 |
| 104 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03892581 |
| 105 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03290563 |
| 106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02961330 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02386836 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01612849 |
| 109 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01498905 |
| 110 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.01382346 |
| 111 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.00767683 |
| 112 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.00767683 |
| 113 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00414867 |
| 114 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00104769 |
| 115 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99649963 |
| 116 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99069411 |
| 117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99025668 |
| 118 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97852922 |
| 119 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97526748 |
| 120 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97363116 |
| 121 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97363116 |
| 122 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97342212 |
| 123 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96896105 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95493602 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95230718 |
| 126 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95005147 |
| 127 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94946196 |
| 128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94739664 |
| 129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94719691 |
| 130 | ERA_21632823_ChIP-Seq_H3396_Human | 0.94680422 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94607392 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.94602361 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94507232 |
| 134 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94079283 |
| 135 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93927899 |
| 136 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93780708 |
| 137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93043683 |
| 138 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.92413683 |
| 139 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.91616104 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91249858 |
| 141 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91189459 |
| 142 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91189459 |
| 143 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91016224 |
| 144 | * MAF_26560356_Chip-Seq_TH1_Human | 0.90539501 |
| 145 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90527391 |
| 146 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.90402659 |
| 147 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90338231 |
| 148 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.90327950 |
| 149 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90214033 |
| 150 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90206227 |
| 151 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.90197013 |
| 152 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90149057 |
| 153 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89642366 |
| 154 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89291901 |
| 155 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89038880 |
| 156 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88846606 |
| 157 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88671316 |
| 158 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88641522 |
| 159 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87981680 |
| 160 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86860485 |
| 161 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.86166347 |
| 162 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85248832 |
| 163 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83924314 |
| 164 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83883793 |
| 165 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83740290 |
| 166 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83723458 |
| 167 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83560928 |
| 168 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83476638 |
| 169 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83422220 |
| 170 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83104771 |
| 171 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82067923 |
| 172 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.81866542 |
| 173 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81634115 |
| 174 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79495936 |
| 175 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77983353 |
| 176 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76934952 |
| 177 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.75871811 |
| 178 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75751284 |
| 179 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.74610387 |
| 180 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.74371209 |
| 181 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73954462 |
| 182 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73784470 |
| 183 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73071977 |
| 184 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72946566 |
| 185 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.72376879 |
| 186 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.70786540 |
| 187 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70588929 |
| 188 | * MYB_26560356_Chip-Seq_TH1_Human | 0.69914969 |
| 189 | VDR_22108803_ChIP-Seq_LS180_Human | 0.69498517 |
| 190 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.69473430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 7.02922354 |
| 2 | MP0005360_urolithiasis | 4.79634337 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.92535014 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 3.55577249 |
| 5 | MP0002254_reproductive_system_inflammat | 3.38237218 |
| 6 | MP0003195_calcinosis | 3.04385104 |
| 7 | MP0003646_muscle_fatigue | 2.80349056 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.65145292 |
| 9 | MP0003136_yellow_coat_color | 2.61500768 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.51060466 |
| 11 | MP0005365_abnormal_bile_salt | 2.47798589 |
| 12 | MP0001790_abnormal_immune_system | 2.47141905 |
| 13 | MP0005387_immune_system_phenotype | 2.47141905 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.46456169 |
| 15 | MP0003252_abnormal_bile_duct | 2.43870149 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.40366332 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.36599331 |
| 18 | MP0005332_abnormal_amino_acid | 2.31822852 |
| 19 | MP0004043_abnormal_pH_regulation | 2.28126722 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26820824 |
| 21 | MP0009643_abnormal_urine_homeostasis | 2.11373867 |
| 22 | MP0002796_impaired_skin_barrier | 2.04055876 |
| 23 | MP0005451_abnormal_body_composition | 1.97132777 |
| 24 | MP0000685_abnormal_immune_system | 1.96979725 |
| 25 | MP0000751_myopathy | 1.91552515 |
| 26 | MP0002234_abnormal_pharynx_morphology | 1.86869554 |
| 27 | MP0001800_abnormal_humoral_immune | 1.86720131 |
| 28 | MP0004036_abnormal_muscle_relaxation | 1.80966087 |
| 29 | MP0002136_abnormal_kidney_physiology | 1.77929882 |
| 30 | MP0004233_abnormal_muscle_weight | 1.67821520 |
| 31 | MP0001765_abnormal_ion_homeostasis | 1.67781703 |
| 32 | MP0000749_muscle_degeneration | 1.65148281 |
| 33 | MP0004510_myositis | 1.64276268 |
| 34 | MP0002653_abnormal_ependyma_morphology | 1.62672391 |
| 35 | MP0005670_abnormal_white_adipose | 1.58275683 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.47633058 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.45952656 |
| 38 | MP0004270_analgesia | 1.45842797 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.45539800 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.43845890 |
| 41 | MP0003011_delayed_dark_adaptation | 1.38710491 |
| 42 | MP0005330_cardiomyopathy | 1.37674162 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.36257300 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.35412578 |
| 45 | MP0004142_abnormal_muscle_tone | 1.32954300 |
| 46 | MP0004087_abnormal_muscle_fiber | 1.28075022 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.26863069 |
| 48 | MP0001756_abnormal_urination | 1.25842442 |
| 49 | MP0003941_abnormal_skin_development | 1.24374739 |
| 50 | MP0005501_abnormal_skin_physiology | 1.23690086 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.23497767 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.22502621 |
| 53 | MP0005266_abnormal_metabolism | 1.21916475 |
| 54 | MP0002060_abnormal_skin_morphology | 1.21197603 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.19784945 |
| 56 | MP0005275_abnormal_skin_tensile | 1.19071772 |
| 57 | MP0002168_other_aberrant_phenotype | 1.19011973 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.18987610 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.18195903 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.16924844 |
| 61 | MP0001853_heart_inflammation | 1.15425624 |
| 62 | MP0003045_fibrosis | 1.12582182 |
| 63 | MP0001873_stomach_inflammation | 1.11938012 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.10583492 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.10550435 |
| 66 | MP0002102_abnormal_ear_morphology | 1.10334620 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10079145 |
| 68 | MP0001529_abnormal_vocalization | 1.08698333 |
| 69 | MP0009046_muscle_twitch | 1.08138669 |
| 70 | MP0004130_abnormal_muscle_cell | 1.08136398 |
| 71 | MP0009764_decreased_sensitivity_to | 1.07375675 |
| 72 | MP0001216_abnormal_epidermal_layer | 1.07322989 |
| 73 | MP0005620_abnormal_muscle_contractility | 1.06953595 |
| 74 | MP0000609_abnormal_liver_physiology | 1.06761358 |
| 75 | MP0000383_abnormal_hair_follicle | 1.06287019 |
| 76 | MP0000747_muscle_weakness | 1.06126201 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.06043826 |
| 78 | MP0004215_abnormal_myocardial_fiber | 1.04789834 |
| 79 | MP0002166_altered_tumor_susceptibility | 1.04543581 |
| 80 | MP0000733_abnormal_muscle_development | 1.04161180 |
| 81 | MP0010329_abnormal_lipoprotein_level | 1.03920113 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 1.03409366 |
| 83 | MP0003879_abnormal_hair_cell | 1.02703065 |
| 84 | MP0000750_abnormal_muscle_regeneration | 1.02632247 |
| 85 | MP0002009_preneoplasia | 1.02527994 |
| 86 | MP0004381_abnormal_hair_follicle | 1.01759346 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 1.00766310 |
| 88 | MP0000579_abnormal_nail_morphology | 0.99526446 |
| 89 | MP0003137_abnormal_impulse_conducting | 0.98402760 |
| 90 | MP0003950_abnormal_plasma_membrane | 0.98295511 |
| 91 | MP0004947_skin_inflammation | 0.97429723 |
| 92 | MP0002106_abnormal_muscle_physiology | 0.97159008 |
| 93 | MP0003878_abnormal_ear_physiology | 0.95437055 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 0.95437055 |
| 95 | MP0002928_abnormal_bile_duct | 0.95365084 |
| 96 | MP0001544_abnormal_cardiovascular_syste | 0.95351033 |
| 97 | MP0005385_cardiovascular_system_phenoty | 0.95351033 |
| 98 | MP0001984_abnormal_olfaction | 0.94585253 |
| 99 | MP0002723_abnormal_immune_serum | 0.94198494 |
| 100 | MP0005647_abnormal_sex_gland | 0.92098372 |
| 101 | MP0005423_abnormal_somatic_nervous | 0.91154820 |
| 102 | MP0001958_emphysema | 0.90155754 |
| 103 | MP0005551_abnormal_eye_electrophysiolog | 0.90146602 |
| 104 | MP0008775_abnormal_heart_ventricle | 0.89934952 |
| 105 | MP0002184_abnormal_innervation | 0.89691735 |
| 106 | MP0002269_muscular_atrophy | 0.89592593 |
| 107 | MP0006138_congestive_heart_failure | 0.89532823 |
| 108 | MP0001346_abnormal_lacrimal_gland | 0.89251071 |
| 109 | MP0002272_abnormal_nervous_system | 0.88660751 |
| 110 | MP0009250_abnormal_appendicular_skeleto | 0.88570495 |
| 111 | MP0002972_abnormal_cardiac_muscle | 0.88408707 |
| 112 | MP0008872_abnormal_physiological_respon | 0.87824580 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.87175923 |
| 114 | MP0002127_abnormal_cardiovascular_syste | 0.87132283 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.86464925 |
| 116 | MP0010630_abnormal_cardiac_muscle | 0.85488686 |
| 117 | MP0005310_abnormal_salivary_gland | 0.82111527 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.81969855 |
| 119 | MP0002148_abnormal_hypersensitivity_rea | 0.81945594 |
| 120 | MP0000538_abnormal_urinary_bladder | 0.81810423 |
| 121 | MP0000026_abnormal_inner_ear | 0.81801908 |
| 122 | MP0000467_abnormal_esophagus_morphology | 0.81801491 |
| 123 | MP0008469_abnormal_protein_level | 0.81686588 |
| 124 | MP0004484_altered_response_of | 0.81661324 |
| 125 | MP0002971_abnormal_brown_adipose | 0.81176187 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.80926883 |
| 127 | MP0004145_abnormal_muscle_electrophysio | 0.80676772 |
| 128 | MP0010678_abnormal_skin_adnexa | 0.80512414 |
| 129 | MP0002420_abnormal_adaptive_immunity | 0.80164437 |
| 130 | MP0006036_abnormal_mitochondrial_physio | 0.79378917 |
| 131 | MP0002098_abnormal_vibrissa_morphology | 0.78458144 |
| 132 | MP0001440_abnormal_grooming_behavior | 0.78097559 |
| 133 | MP0005369_muscle_phenotype | 0.77343525 |
| 134 | MP0000377_abnormal_hair_follicle | 0.76498318 |
| 135 | MP0000955_abnormal_spinal_cord | 0.75872067 |
| 136 | MP0000759_abnormal_skeletal_muscle | 0.75754714 |
| 137 | MP0001968_abnormal_touch/_nociception | 0.74009779 |
| 138 | MP0000372_irregular_coat_pigmentation | 0.73818977 |
| 139 | MP0004147_increased_porphyrin_level | 0.73400982 |
| 140 | MP0006276_abnormal_autonomic_nervous | 0.72205007 |
| 141 | MP0002734_abnormal_mechanical_nocicepti | 0.71767439 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.69763834 |
| 143 | MP0002733_abnormal_thermal_nociception | 0.69674696 |
| 144 | MP0004085_abnormal_heartbeat | 0.68902542 |
| 145 | MP0002822_catalepsy | 0.68578668 |
| 146 | MP0000631_abnormal_neuroendocrine_gland | 0.68471725 |
| 147 | MP0005253_abnormal_eye_physiology | 0.67726136 |
| 148 | MP0009745_abnormal_behavioral_response | 0.66391709 |
| 149 | MP0002277_abnormal_respiratory_mucosa | 0.66126266 |
| 150 | MP0000427_abnormal_hair_cycle | 0.65667937 |
| 151 | MP0000778_abnormal_nervous_system | 0.65664720 |
| 152 | MP0009780_abnormal_chondrocyte_physiolo | 0.65466957 |
| 153 | MP0005174_abnormal_tail_pigmentation | 0.64895946 |
| 154 | MP0003938_abnormal_ear_development | 0.64151695 |
| 155 | MP0001485_abnormal_pinna_reflex | 0.63572371 |
| 156 | MP0002067_abnormal_sensory_capabilities | 0.63144878 |
| 157 | MP0005084_abnormal_gallbladder_morpholo | 0.61571432 |
| 158 | MP0002064_seizures | 0.60834419 |
| 159 | MP0001661_extended_life_span | 0.60583017 |
| 160 | MP0002078_abnormal_glucose_homeostasis | 0.58254695 |
| 161 | MP0000613_abnormal_salivary_gland | 0.58149898 |
| 162 | MP0006072_abnormal_retinal_apoptosis | 0.56102962 |
| 163 | MP0005171_absent_coat_pigmentation | 0.55933163 |
| 164 | MP0003283_abnormal_digestive_organ | 0.55702868 |
| 165 | MP0001970_abnormal_pain_threshold | 0.55515157 |
| 166 | MP0003635_abnormal_synaptic_transmissio | 0.50897483 |
| 167 | MP0005645_abnormal_hypothalamus_physiol | 0.49953000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal finger flexion creases (HP:0006143) | 4.72577300 |
| 2 | Fibular aplasia (HP:0002990) | 4.58666758 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 4.47786688 |
| 4 | Distal arthrogryposis (HP:0005684) | 4.44113751 |
| 5 | Gout (HP:0001997) | 4.24115213 |
| 6 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 4.23855177 |
| 7 | Agammaglobulinemia (HP:0004432) | 4.02663411 |
| 8 | Oligodactyly (hands) (HP:0001180) | 3.90034742 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.90018895 |
| 10 | Hypoplastic pelvis (HP:0008839) | 3.72443552 |
| 11 | Hyperglycinuria (HP:0003108) | 3.67056153 |
| 12 | Rimmed vacuoles (HP:0003805) | 3.61883661 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 3.51333962 |
| 14 | Round ear (HP:0100830) | 3.49340975 |
| 15 | Ketoacidosis (HP:0001993) | 3.48680720 |
| 16 | Proximal tubulopathy (HP:0000114) | 3.46672386 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.46210800 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.44158632 |
| 19 | Calf muscle hypertrophy (HP:0008981) | 3.41567227 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 3.40970722 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 3.39783049 |
| 22 | Ketosis (HP:0001946) | 3.30896293 |
| 23 | Hypokalemic alkalosis (HP:0001949) | 3.26999690 |
| 24 | Increased purine levels (HP:0004368) | 3.26430986 |
| 25 | Hyperuricemia (HP:0002149) | 3.26430986 |
| 26 | Abnormality of chloride homeostasis (HP:0011422) | 3.22950341 |
| 27 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.21646407 |
| 28 | Distal lower limb muscle weakness (HP:0009053) | 3.19442378 |
| 29 | Colitis (HP:0002583) | 3.19351164 |
| 30 | Subaortic stenosis (HP:0001682) | 3.18213760 |
| 31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.18213760 |
| 32 | Split foot (HP:0001839) | 3.16519271 |
| 33 | Polyuria (HP:0000103) | 3.15019983 |
| 34 | Abnormality of purine metabolism (HP:0004352) | 3.14379116 |
| 35 | Muscle fiber splitting (HP:0003555) | 3.14106043 |
| 36 | Metabolic alkalosis (HP:0200114) | 3.13889348 |
| 37 | Increased circulating renin level (HP:0000848) | 3.10558476 |
| 38 | Neck muscle weakness (HP:0000467) | 3.08073254 |
| 39 | Generalized aminoaciduria (HP:0002909) | 3.05902164 |
| 40 | Myotonia (HP:0002486) | 3.04868047 |
| 41 | Ventricular tachycardia (HP:0004756) | 3.03828681 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 3.02701448 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.02701448 |
| 44 | Abnormal urine output (HP:0012590) | 3.01218244 |
| 45 | Hyperactive renin-angiotensin system (HP:0000841) | 3.00818406 |
| 46 | Synostosis involving the elbow (HP:0003938) | 2.95725747 |
| 47 | Humeroradial synostosis (HP:0003041) | 2.95725747 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.94054908 |
| 49 | Absent phalangeal crease (HP:0006109) | 2.93166864 |
| 50 | Muscle stiffness (HP:0003552) | 2.89946538 |
| 51 | Sudden death (HP:0001699) | 2.88939584 |
| 52 | Abnormality of renal excretion (HP:0011036) | 2.88808986 |
| 53 | Myoglobinuria (HP:0002913) | 2.87463765 |
| 54 | Calcaneovalgus deformity (HP:0001848) | 2.85438207 |
| 55 | Muscle fiber inclusion bodies (HP:0100299) | 2.85178453 |
| 56 | Exercise-induced muscle cramps (HP:0003710) | 2.84483387 |
| 57 | Adactyly (HP:0009776) | 2.84380999 |
| 58 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.82010004 |
| 59 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.81882867 |
| 60 | Hypomagnesemia (HP:0002917) | 2.76729919 |
| 61 | Emphysema (HP:0002097) | 2.72445607 |
| 62 | Polydipsia (HP:0001959) | 2.66915445 |
| 63 | Abnormal drinking behavior (HP:0030082) | 2.66915445 |
| 64 | Xanthomatosis (HP:0000991) | 2.63758586 |
| 65 | Hyperammonemia (HP:0001987) | 2.62529597 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.61786742 |
| 67 | Deformed tarsal bones (HP:0008119) | 2.57970529 |
| 68 | Vascular calcification (HP:0004934) | 2.57662664 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 2.57052374 |
| 70 | Radial bowing (HP:0002986) | 2.56888195 |
| 71 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.54901500 |
| 72 | Areflexia of lower limbs (HP:0002522) | 2.50289776 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49641363 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.49641363 |
| 75 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.48184564 |
| 76 | Increased connective tissue (HP:0009025) | 2.48021283 |
| 77 | Intrahepatic cholestasis (HP:0001406) | 2.47110728 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.47078176 |
| 79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.46389233 |
| 80 | Oligodactyly (HP:0012165) | 2.46150203 |
| 81 | Mitral stenosis (HP:0001718) | 2.45307441 |
| 82 | Dehydration (HP:0001944) | 2.44661307 |
| 83 | Hypoglycemic coma (HP:0001325) | 2.44483275 |
| 84 | Hypoplastic nipples (HP:0002557) | 2.43393003 |
| 85 | Alkalosis (HP:0001948) | 2.41385421 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 2.37979049 |
| 87 | Hydroxyprolinuria (HP:0003080) | 2.37979049 |
| 88 | Myocardial infarction (HP:0001658) | 2.35551105 |
| 89 | Facial diplegia (HP:0001349) | 2.35321848 |
| 90 | Asymmetric septal hypertrophy (HP:0001670) | 2.35096829 |
| 91 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.34599822 |
| 92 | Congenital stationary night blindness (HP:0007642) | 2.33741753 |
| 93 | Abnormality of nucleobase metabolism (HP:0010932) | 2.33627141 |
| 94 | Type 1 muscle fiber predominance (HP:0003803) | 2.32209739 |
| 95 | Nemaline bodies (HP:0003798) | 2.31482595 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.31196779 |
| 97 | Abnormality of the pubic bones (HP:0003172) | 2.30699798 |
| 98 | Frequent falls (HP:0002359) | 2.30132461 |
| 99 | Tetany (HP:0001281) | 2.29592471 |
| 100 | Hyperglycinemia (HP:0002154) | 2.27512795 |
| 101 | Ulnar deviation of finger (HP:0009465) | 2.26646129 |
| 102 | Recurrent sinusitis (HP:0011108) | 2.26532705 |
| 103 | Fetal akinesia sequence (HP:0001989) | 2.24702970 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 2.23487938 |
| 105 | Glycosuria (HP:0003076) | 2.23487938 |
| 106 | Bundle branch block (HP:0011710) | 2.20376945 |
| 107 | Myopathic facies (HP:0002058) | 2.19528201 |
| 108 | Recurrent bronchitis (HP:0002837) | 2.19071348 |
| 109 | Hypoplastic iliac wings (HP:0002866) | 2.18300450 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 2.16806429 |
| 111 | Chronic diarrhea (HP:0002028) | 2.15860025 |
| 112 | Widely patent fontanelles and sutures (HP:0004492) | 2.15491045 |
| 113 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.13848433 |
| 114 | Renal tubular acidosis (HP:0001947) | 2.12556287 |
| 115 | EMG: neuropathic changes (HP:0003445) | 2.10821831 |
| 116 | Abnormality of renin-angiotensin system (HP:0000847) | 2.10334301 |
| 117 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.10255230 |
| 118 | Hypokalemia (HP:0002900) | 2.09964938 |
| 119 | Hyperkalemia (HP:0002153) | 2.09673717 |
| 120 | Rickets (HP:0002748) | 2.07906471 |
| 121 | Malignant hyperthermia (HP:0002047) | 2.06881400 |
| 122 | Metabolic acidosis (HP:0001942) | 2.06208950 |
| 123 | EMG: myopathic abnormalities (HP:0003458) | 2.06004077 |
| 124 | Tarsal synostosis (HP:0008368) | 2.05550305 |
| 125 | Fatigable weakness (HP:0003473) | 2.05141428 |
| 126 | Abnormality of the neuromuscular junction (HP:0003398) | 2.05141428 |
| 127 | Generalized muscle weakness (HP:0003324) | 2.04459143 |
| 128 | Delayed gross motor development (HP:0002194) | 2.02726542 |
| 129 | Exercise intolerance (HP:0003546) | 2.02067386 |
| 130 | Abnormality of potassium homeostasis (HP:0011042) | 2.01789806 |
| 131 | Acute necrotizing encephalopathy (HP:0006965) | 2.01150061 |
| 132 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98770242 |
| 133 | Lymphopenia (HP:0001888) | 1.98022986 |
| 134 | IgM deficiency (HP:0002850) | 1.97651853 |
| 135 | Difficulty running (HP:0009046) | 1.96481029 |
| 136 | Abnormality of magnesium homeostasis (HP:0004921) | 1.96115493 |
| 137 | Rhabdomyolysis (HP:0003201) | 1.93726064 |
| 138 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.92056661 |
| 139 | Mitochondrial inheritance (HP:0001427) | 1.91779390 |
| 140 | IgA deficiency (HP:0002720) | 1.91409491 |
| 141 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90673995 |
| 142 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90673995 |
| 143 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.90497724 |
| 144 | Abnormality of the fingertips (HP:0001211) | 1.89413873 |
| 145 | Broad ribs (HP:0000885) | 1.88961952 |
| 146 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.88743120 |
| 147 | Barrel-shaped chest (HP:0001552) | 1.87096002 |
| 148 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86984130 |
| 149 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86428337 |
| 150 | Restrictive lung disease (HP:0002091) | 1.86352250 |
| 151 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.85459575 |
| 152 | Synostosis involving bones of the feet (HP:0009140) | 1.85459575 |
| 153 | Dilated cardiomyopathy (HP:0001644) | 1.85411956 |
| 154 | Verrucae (HP:0200043) | 1.81213489 |
| 155 | Progressive macrocephaly (HP:0004481) | 1.80762262 |
| 156 | Weak cry (HP:0001612) | 1.79823977 |
| 157 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.79057191 |
| 158 | Congenital hip dislocation (HP:0001374) | 1.78959900 |
| 159 | Bulbar palsy (HP:0001283) | 1.74877912 |
| 160 | Muscular dystrophy (HP:0003560) | 1.72920660 |
| 161 | Large for gestational age (HP:0001520) | 1.72544579 |
| 162 | Increased muscle lipid content (HP:0009058) | 1.71014151 |
| 163 | Acute encephalopathy (HP:0006846) | 1.69965363 |
| 164 | Type II lissencephaly (HP:0007260) | 1.68395145 |
| 165 | Molar tooth sign on MRI (HP:0002419) | 1.67887048 |
| 166 | Abnormality of midbrain morphology (HP:0002418) | 1.67887048 |
| 167 | Increased CSF lactate (HP:0002490) | 1.67190084 |
| 168 | Hip contracture (HP:0003273) | 1.66607279 |
| 169 | Limb-girdle muscle atrophy (HP:0003797) | 1.66158594 |
| 170 | Pancreatic fibrosis (HP:0100732) | 1.64558229 |
| 171 | Heart block (HP:0012722) | 1.61495812 |
| 172 | Hepatocellular necrosis (HP:0001404) | 1.61126080 |
| 173 | Gowers sign (HP:0003391) | 1.60013913 |
| 174 | Ventricular fibrillation (HP:0001663) | 1.58596854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 3.85020620 |
| 2 | PINK1 | 3.49361431 |
| 3 | MAP3K14 | 3.09699131 |
| 4 | OBSCN | 3.08438291 |
| 5 | WNK4 | 3.06281310 |
| 6 | MAP4K1 | 3.02063129 |
| 7 | TTN | 2.89733751 |
| 8 | BCKDK | 2.47267214 |
| 9 | ERN1 | 2.36428059 |
| 10 | BMPR1B | 2.32655315 |
| 11 | WNK3 | 2.25492943 |
| 12 | IRAK3 | 2.22041411 |
| 13 | TYK2 | 2.11614544 |
| 14 | FGFR4 | 2.10253085 |
| 15 | JAK1 | 1.91828802 |
| 16 | PIK3CG | 1.90247751 |
| 17 | INSRR | 1.87563545 |
| 18 | MAP4K2 | 1.77581855 |
| 19 | MAP3K3 | 1.72639393 |
| 20 | SIK1 | 1.69742163 |
| 21 | MAP3K13 | 1.69518951 |
| 22 | MUSK | 1.63435023 |
| 23 | EPHB1 | 1.57732371 |
| 24 | PDK4 | 1.57035660 |
| 25 | PDK3 | 1.57035660 |
| 26 | STK24 | 1.54959844 |
| 27 | MAP3K7 | 1.51412123 |
| 28 | NME1 | 1.50297322 |
| 29 | OXSR1 | 1.49682432 |
| 30 | STK38L | 1.47059095 |
| 31 | LRRK2 | 1.44560789 |
| 32 | EPHA3 | 1.41837217 |
| 33 | PHKG2 | 1.36394239 |
| 34 | PHKG1 | 1.36394239 |
| 35 | BTK | 1.35574691 |
| 36 | MST1R | 1.35007269 |
| 37 | CSF1R | 1.33285547 |
| 38 | MARK1 | 1.31271284 |
| 39 | CHUK | 1.30709336 |
| 40 | MAP2K4 | 1.29083947 |
| 41 | IKBKB | 1.27994683 |
| 42 | WNK1 | 1.27379941 |
| 43 | BLK | 1.26204606 |
| 44 | ERBB3 | 1.25013347 |
| 45 | PTK6 | 1.23735915 |
| 46 | TGFBR1 | 1.22590209 |
| 47 | ADRBK2 | 1.22276255 |
| 48 | GRK1 | 1.17471610 |
| 49 | PRKAA2 | 1.14417912 |
| 50 | MAPK13 | 1.11537874 |
| 51 | MST4 | 1.09675593 |
| 52 | DYRK1B | 1.09508252 |
| 53 | TBK1 | 1.07684808 |
| 54 | TGFBR2 | 1.04553044 |
| 55 | STK10 | 1.03821090 |
| 56 | GRK6 | 1.01387777 |
| 57 | MAP2K3 | 0.99406568 |
| 58 | LATS1 | 0.98195393 |
| 59 | PKN1 | 0.96731536 |
| 60 | TLK1 | 0.94357951 |
| 61 | DAPK2 | 0.93412759 |
| 62 | SYK | 0.91732215 |
| 63 | MAPK15 | 0.90292571 |
| 64 | IKBKE | 0.90055517 |
| 65 | TRIB3 | 0.90015272 |
| 66 | PDK2 | 0.89827947 |
| 67 | FRK | 0.88678426 |
| 68 | IRAK4 | 0.87063414 |
| 69 | CDK12 | 0.87020918 |
| 70 | MAPKAPK3 | 0.83746617 |
| 71 | MAPK12 | 0.82561747 |
| 72 | CDC42BPA | 0.81342953 |
| 73 | DMPK | 0.80579171 |
| 74 | JAK3 | 0.79721748 |
| 75 | TRPM7 | 0.78583114 |
| 76 | CDK8 | 0.77735571 |
| 77 | PIK3CA | 0.77492956 |
| 78 | CAMK2G | 0.76729062 |
| 79 | PRKCQ | 0.76539391 |
| 80 | PTK2B | 0.76329538 |
| 81 | STK39 | 0.76106705 |
| 82 | MAPK11 | 0.75974341 |
| 83 | PRKD1 | 0.73046660 |
| 84 | FGFR3 | 0.72446910 |
| 85 | PRKAA1 | 0.72340885 |
| 86 | CSK | 0.71205050 |
| 87 | PRKD2 | 0.70278997 |
| 88 | TIE1 | 0.67127284 |
| 89 | TNK2 | 0.66848133 |
| 90 | CAMK2D | 0.66635137 |
| 91 | CAMK2A | 0.64765143 |
| 92 | CAMK2B | 0.64648993 |
| 93 | DYRK2 | 0.64571014 |
| 94 | MAP3K4 | 0.62148776 |
| 95 | SIK3 | 0.62073257 |
| 96 | MARK3 | 0.61702421 |
| 97 | SGK3 | 0.60704810 |
| 98 | FER | 0.60619191 |
| 99 | MAP2K1 | 0.60523870 |
| 100 | CAMK1 | 0.60478614 |
| 101 | CCNB1 | 0.60278297 |
| 102 | NEK1 | 0.59538773 |
| 103 | HCK | 0.59278560 |
| 104 | ITK | 0.57594817 |
| 105 | MAP3K10 | 0.56429489 |
| 106 | ADRBK1 | 0.55994420 |
| 107 | NUAK1 | 0.55764042 |
| 108 | MYLK | 0.55360629 |
| 109 | KIT | 0.54121412 |
| 110 | JAK2 | 0.51305623 |
| 111 | ABL1 | 0.51073370 |
| 112 | ZAK | 0.50400953 |
| 113 | SGK2 | 0.49523188 |
| 114 | ROCK1 | 0.48371457 |
| 115 | CAMK4 | 0.47867331 |
| 116 | MAP2K7 | 0.47752029 |
| 117 | MAPK7 | 0.46650263 |
| 118 | PRKACA | 0.46108484 |
| 119 | PRKG1 | 0.45750129 |
| 120 | PIM1 | 0.45389699 |
| 121 | NEK9 | 0.44437128 |
| 122 | SGK494 | 0.43441586 |
| 123 | SGK223 | 0.43441586 |
| 124 | IRAK1 | 0.43393432 |
| 125 | LYN | 0.43196128 |
| 126 | SIK2 | 0.42977817 |
| 127 | RIPK4 | 0.42971523 |
| 128 | GRK7 | 0.42572006 |
| 129 | STK3 | 0.42471768 |
| 130 | AKT2 | 0.41795477 |
| 131 | FLT3 | 0.40421448 |
| 132 | SGK1 | 0.38690353 |
| 133 | MAP2K6 | 0.38294028 |
| 134 | PAK3 | 0.37636820 |
| 135 | NLK | 0.36513886 |
| 136 | ACVR1B | 0.36217501 |
| 137 | LIMK1 | 0.34955280 |
| 138 | CSNK1G2 | 0.33833981 |
| 139 | RPS6KB1 | 0.32225227 |
| 140 | PRKCG | 0.31792674 |
| 141 | MOS | 0.29071346 |
| 142 | CASK | 0.28740125 |
| 143 | TAOK3 | 0.28625805 |
| 144 | STK11 | 0.25924985 |
| 145 | PNCK | 0.24270025 |
| 146 | RPS6KA3 | 0.24028386 |
| 147 | PRKCI | 0.23554798 |
| 148 | MAPKAPK5 | 0.22988070 |
| 149 | MET | 0.22790811 |
| 150 | CSNK1A1 | 0.22211394 |
| 151 | MAPK4 | 0.21977053 |
| 152 | PRKCZ | 0.21241568 |
| 153 | RPS6KA6 | 0.19685435 |
| 154 | PRKCE | 0.18363005 |
| 155 | CAMKK2 | 0.17158503 |
| 156 | CDK9 | 0.17125714 |
| 157 | PRKACB | 0.16380417 |
| 158 | MAP2K2 | 0.15839448 |
| 159 | RPS6KA1 | 0.15725316 |
| 160 | RPS6KB2 | 0.14565334 |
| 161 | PRKCA | 0.13579886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.86307921 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.09383237 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.01859613 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.98005479 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.91995551 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86035677 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.74874771 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69992345 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.41635346 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.36497964 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.34333574 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31845507 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29520647 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.28540231 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.26763483 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 2.22300539 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.06957365 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03068837 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.99842308 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.99769438 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97541719 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.86416323 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.76230548 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.75461333 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74898691 |
| 26 | Lysine degradation_Homo sapiens_hsa00310 | 1.73303839 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73045115 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72860923 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71604220 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67910904 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67174795 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.60536190 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60038651 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.59001380 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56414147 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56199085 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.53561141 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43272192 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42791648 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42068452 |
| 41 | Insulin secretion_Homo sapiens_hsa04911 | 1.39371190 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37700529 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33758494 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33042690 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30162843 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29922175 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.29089459 |
| 48 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.26504057 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.25483686 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.23527591 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19267408 |
| 52 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.18071988 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.17186208 |
| 54 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16483470 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15839018 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14268607 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13371277 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11868594 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 1.11731691 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08237511 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06616684 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06253862 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05332721 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 1.05069003 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04207135 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02039595 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01418359 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 1.00202098 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99472582 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.99202573 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97878864 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.96148730 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95723988 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95004201 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94998577 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.89805056 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.89473399 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88864557 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.88246274 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.83002494 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81445875 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.81260916 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81079209 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80180326 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80048899 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.75184013 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73783290 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72220776 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71583740 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71180481 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69831407 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68215983 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67868148 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66018307 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65473225 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64574827 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.64469658 |
| 98 | Protein export_Homo sapiens_hsa03060 | 0.63657002 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63438151 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60476065 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60195472 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59870475 |
| 103 | RNA polymerase_Homo sapiens_hsa03020 | 0.58765322 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55921607 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54289945 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.52925151 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52193116 |
| 108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50941035 |
| 109 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.50377594 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48230265 |
| 111 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47779107 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45982060 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45055134 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44855176 |
| 115 | Taste transduction_Homo sapiens_hsa04742 | 0.44457616 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44354724 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43116424 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42803555 |
| 119 | Long-term depression_Homo sapiens_hsa04730 | 0.42746640 |
| 120 | GABAergic synapse_Homo sapiens_hsa04727 | 0.42725649 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42624490 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42482011 |
| 123 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40104181 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38987335 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38643178 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37487378 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.37086466 |
| 128 | Tight junction_Homo sapiens_hsa04530 | 0.36931820 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35744413 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35198793 |
| 131 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34323517 |
| 132 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33367628 |
| 133 | Ribosome_Homo sapiens_hsa03010 | 0.33283232 |
| 134 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32768552 |
| 135 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31663422 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30810930 |
| 137 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29510645 |
| 138 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.28057159 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28041365 |
| 140 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27561212 |
| 141 | Leishmaniasis_Homo sapiens_hsa05140 | 0.27543945 |
| 142 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26872218 |
| 143 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26337393 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25048627 |
| 145 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24626461 |
| 146 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21512574 |
| 147 | Hepatitis C_Homo sapiens_hsa05160 | 0.21102153 |
| 148 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.19835166 |
| 149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19462238 |
| 150 | Mineral absorption_Homo sapiens_hsa04978 | 0.18126355 |
| 151 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15896942 |
| 152 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.15645636 |
| 153 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.15289096 |
| 154 | Tuberculosis_Homo sapiens_hsa05152 | 0.15123282 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15076213 |

